1 / 76

Poland IVF Service Market Analysis Sample Report 2022 to 2030

This report presents a strategic analysis of the Poland In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term.

Insights10
Download Presentation

Poland IVF Service Market Analysis Sample Report 2022 to 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Poland In Vitro Fertilization (IVF) Service Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2023 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Poland In Vitro Fertilisation (IVF) Service Market Analysisand a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Poland In Vitro Fertilisation (IVF) Service Market Analysis, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Click on the icon to know the detailed methodology

  4. Our Understandings Recharge Capital Summary Report Objective Key Insight • Sector-focused financial engineers who carry interdisciplinary backgrounds across asset classes • Guided by specific value chain frameworks in sectors with strong macro tailwinds, Recharge Capital invests with agile vehicles to best capture the opportunities in the targeted themes • It has themes of synthetic biology, semiconductor enablements, digital assets, women’s healthcare and fintech infrastructure • Assessing the current size and growth potential of the Poland In Vitro Fertilisation (IVF) Service Market • Identifying the key trends in the Poland In Vitro Fertilisation (IVF) Service Market • Analyzing the competitive landscape of the Poland In Vitro Fertilisation (IVF) Service Market • Providing insights into the regulatory landscape of the Poland In Vitro Fertilisation (IVF) Service Market • Increase of Infertility among couples in Poland, increase in mean age of child bearing women in Poland • This is driving the demand for In Vitro Fertilisation (IVF) ServiceMarket in Poland • Technological developments of in vitro fertilization and rising medical tourism in Poland due to low living cost also acts as market growth driver

  5. Table of Content

  6. Table of Content

  7. Poland In Vitro Fertilisation (IVF) Service Market Analysis 1. In Vitro Fertilisation (IVF) Service Market Overview

  8. 1.1 Statistics at a Glance: In Vitro Fertilisation (IVF) Service Market in the World • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Prevalence of In Vitro Fertilisation (IVF) Service Market $ 696 Mn Global in vitro fertilization service market size in 2022 8%-10% Couples globally suffer from infertility which is around 80 million couples worldwide according to WHO 17.5% Lifetime prevalence of infertility in low and middle income countries 16.5% Lifetime prevalence of infertility in low and middle income countries 8.9% CAGR at which global in vitro fertilization service market size is expected to grow from 2022-2030 10-15% Couples globally suffer from secondary infertility that is inability to have second offspring

  9. 1.1 Statistics at a Glance:In Vitro Fertilisation (IVF) Service Market in the World Europe ~Revenue to reach $6.29 Bn by 2030 North America ~ Market Size of $8.9 Bn Asia -Fastest CAGR Africa ~Market Size of $0.26 Bn Poland Market ~$103 Mn Illustrative

  10. 1.2 Poland Overview • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 38.5 Mn Is the population of Poland, in 2022 $688 Bn Is the Gross Domestic Product (GDP) in Poland in 2022 41.3 Is the median age in Poland , in 2022 $3.34 k per capita was the amount of national health expenditures in 2022

  11. 1.3 Economic Overview: Poland Population of Poland , (2020-2030) GDP of Poland , (2020-2030) Population Split (2023) • In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest By Gender By Age Group 0-14 15-24 25-54 55-64 65+ Illustrative

  12. 1.4 Poland In Vitro Fertilisation (IVF) Service Market • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Poland • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Prevalence of IVF Services 15-20% Polish couples suffer from infertility 36 Years is average age of women seeking for fertility treatment $3696 Price of IVF treatment using own eggs in Poland 3.4% Population is suffering from infertility in Poland 35.2% Success rate of in-vitro fertilization procedures in Poland $103 Mn Market size of IVF services in Poland

  13. 1.5 Healthcare Services in Poland Poland Healthcare Services Market Forecast, 2022-2030 (in $Bn) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the overall Healthcare Services market in Poland , which includes the market size, current trends and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

  14. 1.6 Healthcare Scenario in Poland • Primary and Specialist Care: The healthcare system in Poland includes primary care facilities such as clinics and general practitioners, as well as specialized healthcare services provided by specialists in hospitals and outpatient clinics. Patients generally need a referral from a primary care physician to access specialist care • Infrastructure and Facilities: Poland has a well-developed healthcare infrastructure with a network of hospitals, clinics, and healthcare facilities across the country. Major cities have modern hospitals equipped with advanced medical technologies, while rural areas may have limited healthcare resources and face challenges in terms of accessibility • Waiting Times: Waiting times for certain medical procedures and specialist appointments can be a challenge in the Polish healthcare system. This can result from a shortage of specialists, high patient demand, and resource constraints. Efforts are being made to reduce waiting times and improve access to healthcare services • Public and Private Healthcare: In addition to the public healthcare system, Poland also has a private healthcare sector. Private healthcare providers offer services that are not covered by the public system, and individuals can choose to access private healthcare services by paying out-of-pocket or purchasing private health insurance • Healthcare Funding: The Polish healthcare system is funded through a combination of public funds, including contributions from employees and employers, as well as government allocations from the state budget. The National Health Fund plays a key role in managing and allocating healthcare funds • Digitalization and E-health: Poland is embracing digitalization in healthcare with the implementation of e-health solutions. Electronic medical records, telemedicine, and online appointment booking systems are being introduced to improve healthcare efficiency, accessibility, and patient outcomes • Pharmaceutical Industry: Poland has a well-established pharmaceutical industry and is a major market for pharmaceutical products. The country also produces some generic drugs, which contribute to cost savings in healthcare

  15. 1.6 Healthcare Scenario: Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Imaging (confirm bone related changes or respiratory problems) Initial Diagnosis Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: • Stroke: Chronic transfusions, HU Genetic testing (detect the type of SCD) PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist Stakeholders Depending on the organ complications, the treatment involves different specialists at different times Illustrative

  16. 1.7 Health Insurance Coverage: Poland % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage • In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year • More people had private health insurance (66%) than public coverage (35.7%) • Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Private insurance (18.9%), Public insurance (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) Illustrative

  17. 1.8 Budget of Poland Government for Public Insurance • National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) • Public spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE • Private spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE • Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE • Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE • Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE • Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 • Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 • Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 • Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% Illustrative

  18. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) Strategic Buyers Financial Buyers $100+ $50-$100 $25-$50 $0- $25 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative

  19. 1.9 Mergers and Acquisitions (continued) Latest Deals In Poland Illustrative

  20. Poland In Vitro Fertilisation (IVF) Service Market Analysis 2. Market Size and Forecasting

  21. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Poland In Vitro Fertilisation (IVF) Service Market Forecast, 2022-2030(in $Bn) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the overall In Vitro Fertilisation (IVF) ServiceMarket in Poland, which includes the market size, current trends and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest CAGR~ XX% Illustrative

  22. 2.2 Snapshot of Poland In Vitro Fertilisation (IVF) Service Market Segmentation By Product By Cycle By Type End-User Equipment Fresh Non-donor IVF Cycles Conventional IVF Fertility Clinics Reagents & Media Frozen Non-donor IVF Cycles IVF with ICSI Hospitals & Surgical Centers Cryobanks Frozen Donor IVF Cycles IVF with Donor Eggs Accessories Fresh Donor IVF Cycle Others • In this section you will get an understanding of the segmentations which will cover the Poland IVF Service Market • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report

  23. 2.2.1 Market Segmentation: By Product • Equipment: • Sperm Analyzer Systems • Imaging Systems • Ovum Aspiration Pumps • Micromanipulator Systems • Incubators • Gas Analysers • Laser Systems • Cryosystems • Sperm Separation Devices • IVF Cabinets • Anti-vibration Tables • Witness Systems • Reagents & Media • Cryopreservation Media • Embryo Culture Media • Ovum Processing Media • Sperm Processing Media • Accessories Poland IVF Service Market Share, By Product (2022)

  24. 2.2.2 Market Segmentation: By Cycle • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Poland IVF Service Market Share, By Cycle Type (2022)

  25. 2.2.3 Market Segmentation: By Type • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Poland IVF Service Market Share, By Type (2022)

  26. 2.2.4 Market Segmentation: By End-User • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Poland IVF Service Market Share, By End-User (2022)

  27. Poland In Vitro Fertilisation (IVF) Service Market Analysis 3. Market Dynamics

  28. 3.1 Market growth drivers 3.1.1 Increasing age of women at child birth, In 2022, the average age was 30.2years. This is an increase from the average age of 29.7years in 2020 Increasing Age of Women at Child Birth • Increase in age of women decreases the fertility of women and this acts as a market growth driver for in vitro fertilization in Poland • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest xx% Illustrative

  29. 3.1 Market growth drivers (continued) 3.1.2 Technological Advancement like Cryopreservation, ICSI, PICSI, PGD, PGS. In 2022, the government allocated about $2.3 Mn for research and development in IVF Services and Private companies allocated about $1.1 Mn Top countries that are leveraging technology for R&D in IVF services • Poland is highly technologically equipped when it comes to IVF technology and various research and development activities are going on for the same which acts as a market growth driver • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

  30. 3.1 Market growth drivers (continued) 3.1.3 Increasing medical tourism in Poland. In 2022, Poland is estimated to have welcomed over 442,900medical tourists. This is a significant increase from the378,000medical tourists who visited Poland in 2020. Medical Tourism in Poland • Medical tourism in Poland is increasing at a high rate due to low cost of living in Poland as compared to rest countries in Europe and latest medical technologies in Europe • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest xx% Illustrative

  31. 3.2 Market restraints 3.2.1 3.2.1 In 2022, the average cost of a IVF was around €3,000, which depends on the clinic and specific treatment 3.2.2 Success rate for IVF service is 30% in Poland, which varies depending on different factors 3.2.3 Lack of insurance coverage in Poland because there is no universal health insurance coverage • Due to less success rate of IVF procedure patients are hesitant to go for the procedure • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest • IVF procedure is expensive and this acts as a market growth restraint for IVF Service market in Poland • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest • Insurance and reimbursement challenge also acts as a market growth restraint • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative

  32. Poland In Vitro Fertilisation (IVF) Service Market Analysis 4. Competitive Landscape

  33. 4.1 Major Market Share Revenue of Major players in Poland IVF Service Market ($ Mn) • Poland IVF Service Market is a highly competitive space, with many companies developing and marketing cancer treatments • Some of the top companies in Poland IVF Service Market based on revenue and market share include • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

  34. 4.2 Key Company Profile Key Note: 1 InviMed • Here is the list of top 10 companies which will cover in the final report • Each company will have slides for • Overview • Key details • Offerings • Name of products • Recent activities/ Press Coverage • Distribution and Vendor Partners • Mergers, Acquisitions and Collaboration • Financials • If there are specific companies that you would like to be included in the report, please let us know via email • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report 2 Bloom IVF 3 CCRM Fertility 4 Oxford Fertility 5 Create Health 6 Medicover 7 Aevitas Fertility Clinic 8 BioART Fertility Clinic 9 Prelude Fertility 10 Genesis Illustrative

  35. 4.2.1 InviMed Founded in: 1995 HQ: Warsaw, Poland Type: Private Revenue: - Website: www.invimed.pl • InviMed offers a full range of IVF services, including egg donation, embryo donation, and gestational surrogacy • InviMed's success rate for IVF is over 54%. This is higher than the average success rate for IVF in Poland, which is around 35% • Polish Ministry of Health and the European Society of Human Reproduction and Embryology has accredited InviMed which indicates the clinic's high standards of quality and safety Recent Activity / Press Coverage InviMed Illustrative

  36. 4.2.1 InviMed (continued) Partnerships Ecosystem Major Vendor Partners Major Distribution Partners Illustrative

  37. 4.2.1 InviMed (continued) Latest Deals - Mergers and Acquisitions Illustrative

  38. 4.2.1 InviMed (continued) Revenues ($Bn), 2020-2030 • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Breakdown of Net Revenue by Segment, 2022 Illustrative

  39. 4.2.2 Company 2 Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Illustrative

  40. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Vendor Partners Major Distribution Partners Illustrative

  41. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Illustrative

  42. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Breakdown of Net Revenue by Segment, 2022 Illustrative

  43. Poland In Vitro Fertilisation (IVF) Service Market Analysis 5. Reimbursement Scenario

  44. 5.1 Reimbursement Regulation Public insurance and Private insurance together provide health insurance coverage for more than 4 in 10 Polandns The reimbursement scenario in the US cancer market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: • Public Insurance: • Public insurance is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions • Public insurance covers many cancer treatments, including chemotherapy, radiation therapy, and some immunotherapies • However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization • Private Insurance: • Private insurance is a joint federal-state program that provides health insurance for people with low incomes • Private insurance coverage for cancer treatments can vary by state, and may be subject to limits on the amount and type of treatment covered • Private insurance coverage for cancer treatments can also vary widely depending on the insurer and the specific policy • Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Health Insurance Coverage, 2022 Illustrative

  45. 5.1 Reimbursement Regulation (continued) • Affordable Care Act: • Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover certain preventive services, including cancer screenings, without co-pays or deductibles • It also includes protections for people with pre-existing conditions, such as cancer • Reimbursement for New Treatments: • Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage • This can create challenges for companies developing and marketing new treatments • Value-Based Care: • There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments • Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

  46. 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) • Public healthcare coverage is provided by the government and includes programs like Public insurance and Private insurance • Public insurance is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities • Private insurance is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources Reimbursement Market Trends • Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs • This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative

  47. 5.2 Reimbursement Process for In Vitro Fertilisation (IVF) ServiceDiagnosis The reimbursement process in the Poland healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: • Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient • Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided • Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud • Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule • Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

  48. 5.3 Reimbursement Process for In Vitro Fertilisation (IVF) ServiceTreatment The reimbursement process in the Poland healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: • Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient • Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided • Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud • Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule FDA Market Authorization Private Payers Public Payers Health Technology Assessment Coding Coverage Payment 1 2 3 Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative

  49. Poland In Vitro Fertilisation (IVF) Service Market Analysis 6. Methodology & Scope

  50. Research Methodology • Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions • We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources • For forecasting, the following parameters are considered: • Market drivers and restraints along with their current and expected impacts • Technological scenario and expected developments • End use industry trends and dynamics • Trends in the consumer behavior • Regulatory scenario and expected developments • Current capacity and expected capacity additions up to 2030 • We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate • We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions • All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) • Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

More Related